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Background: Recent attempts to translate Sepsis-3 criteria to children have been
restricted to PICU patients and did not target children in emergency departments (ED).
We assessed the prognostic accuracy of the age-adjusted quick Sequential Organ
Failure Assessment score (qSOFA) and compared the performance to SIRS and the
quick Pediatric Logistic Organ Dysfunction-2 score (qPELOD-2). We studied whether
the addition of lactate (qSOFA-L) would increase prognostic accuracy.
Methods: Non-academic, single-center, retrospective study in children visiting the ED
and admitted with suspected bacterial infection between March 2013 and January 2018.
We defined suspected bacterial infection as initiation of antibiotic therapy within 24 h after
ED entry. Age-adjusted qSOFA, SIRS, qPELOD-2, and qSOFA-L scores were compared
by area under the receiver operating characteristics curve (AUROC) analysis. Primary
outcome measure was PICU transfer and/or mortality and secondary outcome was
prolonged hospital length of stay.
Results: We included 864 ED visits [474 (55%) male; median age 2.5 years;
IQR 9 months-6 years], of which 18 were transferred to a PICU and 6 ended in
death [composite outcome PICU transfer and/or mortality; 23 admissions (2.7%)].
179 (22.2%) admissions resulted in prolonged hospital length of stay. PICU
transfer and/or death was present in 22.5% of visits with qSOFA≥2 (n = 40)
compared to 2.0% of visits with qSOFA<2 (n = 444) (p < 0.01). qSOFA tends
to be the best predictor of PICU transfer and/or mortality (AUROC 0.72 (95%
CI, 0.57–0.86) compared to SIRS [0.64 (95% CI, 0.53–0.74), p = 0.23] and
qPELOD-2 [0.60 (95% CI, 0.45–0.76), p = 0.03)]. Prolonged hospital length of stay
was poorly predicted by qSOFA (AUROC 0.53, 95% CI 0.46–0.59), SIRS (0.49,
95% CI 0.44–0.54), and qPELOD-2 (0.51, 95%CI 0.45–0.57). qSOFA-L resulted in
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an AUROC of 0.67 (95%CI, 0.50–0.84) for PICU transfer and/or mortality and an AUROC
of 0.56 (95% CI, 0.46–0.67) for prolonged hospital length of stay.
Conclusion: The currently proposed bedside risk-stratification tool of Sepsis-3 criteria,
qSOFA, shows moderate prognostic accuracy for PICU transfer and/or mortality in
children visiting the ED with suspected bacterial infection. The addition of lactate did
not improve prognostic accuracy. Future prospective studies in larger ED populations
are needed to further determine the utility of the qSOFA score.
Keywords: Sepsis-3, (q)SOFA, SIRS, (q)PELOD-2, risk-stratification, prognosis, outcome, pediatrics
INTRODUCTION
As SIRS criteria lack specificity when identifying patients
with infection who are at higher risk of mortality, the Adult
Sepsis Definition Taskforce published the Third International
Consensus Definitions for Sepsis and Septic Shock in 2016 (1).
This new Sepsis-3 consensus emphasizes that sepsis can be
differentiated from uncomplicated infection by the existence of
a dysregulated host response, manifested as hazardous organ
dysfunction. The Sequential Organ Failure Assessment (SOFA)
score was suggested to be used as a discriminator of in-hospital
mortality and has been validated in adult patients with suspected
or confirmed infection (1, 2). The quick SOFA (qSOFA) score,
incorporating only altered mentation, systolic blood pressure
and respiratory rate, has been suggested as manageable bed-
side tool to promptly identify infectious patients prone to
poor outcomes, and could therefore be especially useful in
the Emergency Department (ED) (1, 2). Since publication of
the Sepsis-3 consensus, several adult studies in ICU and ED
populations have reported that both SOFA- and qSOFA score
have better prognostic accuracy compared to formerly used sepsis
criteria (2–5).
Regrettably, the Sepsis-3 taskforce excluded pediatric
populations from development and validation. Hence, there is
a remaining demand for data-driven pediatric sepsis criteria,
especially because of pediatric specific challenges in sepsis
recognition. Firstly, febrile children present to the ED with
milder infections of lower acuity compared to adults. Secondly,
pediatric sepsis could have a more fulminant course compared
to adults and death could occur very early (6–8), making early
recognition even more crucial. Several recent attempts have
been made to translate Sepsis-3 criteria to children (9) and
although the SOFA score has originally only been validated in
patients above 12 years of age (10, 11), age-adapted SOFA and
qSOFA show promising results in children admitted to a PICU.
Matics and Sanchez-Pinto published a SOFA AUROC of 0.94
for in-hospital mortality (12) and Schlapbach and colleagues
reported superior discrimination of age-adjusted SOFA for
mortality compared to PELOD-2 and SIRS (13). In the latter,
qSOFA performance was slightly better than SIRS, though
inferior to SOFA and PELOD-2 scores. A large limitation of
these studies is however that they were limited to the PICU,
whereas earliest possible recognition of sepsis should occur in
the ED.
The aim of this study is to assess the accuracy of the qSOFA
score in predicting outcome among children presenting at the
ED with suspected bacterial infection. Additionally, we compare
our findings with SIRS criteria and the qPELOD-2 score. Lastly,
since lactate could be measured in a timely, practically bedside,
manner, we hypothesized that the qSOFA score would perform
better with lactate included (qSOFA-L) in the risk stratification
tool.
MATERIALS AND METHODS
Study Population
We performed a non-academic single-center retrospective
study in patients <18 years who visited the ED and were
subsequently admitted to the pediatric ward with suspected
bacterial infection between March 2013 and January 2018. We
defined suspected bacterial infection as initiation of therapeutic
antibiotic therapy within 24 h after ED entry. We considered
11 antibiotics as therapeutic; amoxicillin, amoxicillin clavulanic
acid, benzylpenicillin, cefotaxime, ceftazidime, ceftriaxone,
cefuroxime, clarithromycin, clindamycin, flucloxacillin, and
vancomycin. Patients admitted with a surgical diagnosis were
excluded.
Clinical Data Collection
Data was retrieved electronically via the hospital patient
information system. Data on demographics, antibiotic treatment,
vital signs (temperature, heart rate, diastolic, and systolic blood
pressure, respiratory rate), laboratory values (lactate, white
blood cell count), level of consciousness (AVPU scale, Glasgow
Coma Scale) (14), hospital length of stay, PICU transfer and
mortality were collected. We calculated four sepsis scores;
qSOFA (13), SIRS (15, 16), qPELOD-2 (17, 18), and qSOFA-L
(Supplementary Table 1 presents age-adapted scores). These
scores were based on the first measured values within 24 h after
ED entry. A threshold of two or more points was used to indicate
a positive test result for every sepsis score. If only 1 variable was
not obtained (i.e., not measured in the first 24 h of admission),
we considered this variable to be normal (i.e., no contribution
was made to the total score). If two or more variables were
not obtained, the total score was considered missing in order
to prevent false-negative scores. Cut-off value for lactate was
2mmol/L (19).
Outcomes Measures
The primary outcome measure was a composite of PICU transfer
(to an academic, tertiary care center) and/or mortality. Criteria
for PICU transfer were cardio-respiratory or neurological failure.
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The secondary outcome measure was prolonged hospital length
of stay, defined as a hospital length of stay of 7 days or longer.
Statistical Analysis
Statistical analyses were performed using SPSS version 24.0
(Armonk, USA). Normality of distribution was assessed through
Shapiro-Wilk analysis. Data is presented as percentages, means
with standard deviation or medians with ranges, as appropriate.
χ
2-tests were used to compare categorical data by subgroups. We
measured the prognostic accuracy of each sepsis score using the
area under the receiver operating characteristics curve (AUROC).
AUROC comparison was performed using the DeLong method
(20) withMedCalc version 18.2.1. Sensitivity, specificity, negative
predictive value (NPV) and positive predictive value (PPV) were
calculated for each score. P < 0.05 were considered statistically
significant.
Ethical Aspects
This study was conducted in accordance with the Declaration
of Helsinki and Good Clinical Practice guidelines. The study
protocol was approved by the local ethical review board (MEC-
2018-1063). Necessity for written informed consent was waived.
RESULTS
Study Population
We identified 864 ED visits (55% males) with suspected bacterial
infection that resulted in admission. Median age was 2.5 years
(IQR 9 months-6 years). Six admissions (0.7%) ended in death
within 30 days and 18 children (2.1%) were transferred to a
PICU. Causes of death were; neurological failure due to cerebral
hemophagocytic lymphohistiocytosis (n = 1), respiratory failure
due to viral infection (n = 2) and aspiration pneumonia (n = 1),
pulmonary artery embolus as a result of ethmoiditis (n = 1),
and cardiorespiratory failure due to pneumonia (n = 1). The
composite outcome; PICU transfer and/or death occurred in a
total of 23 (2.7%) admissions (equivalent to 23 children). For
806 (93%) ED encounters, the total hospital length of stay was
known, of which 179 (22.2%) patients were admitted during 7
days or longer. Of 864 visits, data on temperature was obtained
in 855 (99%) patients (median time after ED entry 24min (IQR
5-62), on heart rate in 784 (91%) patients (median time after
ED entry 24min (IQR 5-68), on systolic blood pressure in 269
(31%) patients (median time after ED entry 86min (IQR 14-
290), on respiratory rate in 676 (78%) patients (median time after
ED entry 29min (IQR 6-100), on lactate in 39 (4.5%) patients
(median time after ED entry 71min (IQR 20-471), on white
blood cell count in 663 (77%) patients (median time after ED
entry 65min (IQR 35-111), and on level of consciousness in
426 (49%) patients (median time after ED entry 34min (IQR 9-
135). qSOFA, SIRS, qPELOD-2, and qSOFA-lactate scores were
positive for 40 out of 484 (8.3%), 415 out of 755 (55%), 11
out of 545 (2.0%), and 40 out of 151 (26.5%) visits, respectively
(Figure 1).
Performance qSOFA Score
In patients with qSOFA ≥ 2, PICU transfer and/or mortality
prevalence was 22.5% compared to 2.0% in patients with
FIGURE 1 | Distribution of qSOFA, SIRS, qPELOD-2, and qSOFA-L scores in pediatric ED encounters with suspected bacterial infection.
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TABLE 1 | Prognostic accuracy of positive qSOFA, SIRS, qPELOD-2, and qSOFA-L scores for PICU transfer and/or mortality and prolonged hospital length of stay.
Primary outcome: PICU
transfer and/or mortality
Secondary outcome: Prolonged
hospital LOS (≥7 days)
Comparison to AUROC
qSOFA positive
Area under the
curve (95% CI)
Area under the
curve (95% CI)
P-value 1st outcome P-value 2nd outcome
qSOFA positive 0.72 (0.57–0.86) 0.53 (0.46–0.59) – –
SIRS positive 0.64 (0.53–0.74) 0.49 (0.44–0.54) 0.23 0.82
qPELOD-2 positive 0.60 (0.45–0.76) 0.51 (0.45–0.57) 0.03 0.25
qSOFA-lactate positive 0.67 (0.50–0.84) 0.56 (0.46–0.67) <0.01 0.58
Primary outcome: PICU transfer and/or mortality
Sensitivity (%) Specificity (%) Negative predictive
value (%)
Positive predictive
value (%)
qSOFA positive 50.0 93.3 98.0 22.5
SIRS positive 81.8 45.8 98.8 4.3
qPELOD-2 positive 22.2 98.7 97.4 36.4
qSOFA-lactate positive 58.3 76.3 95.5 17.5
Secondary outcome: Prolonged hospital length of stay (≥7 days)
Sensitivity (%) Specificity (%) Negative predictive
value (%)
Positive predictive
value (%)
qSOFA positive 5.8 89.0 21.6 64.5
SIRS positive 55.0 47.7 22.2 79.6
qPELOD-2 positive 1.0 97.3 22.3 57.1
qSOFA-lactate positive 21.2 65.9 30.2 54.5
Prevalence PICU transfer and/or mortality
Positive
score (%)
Negative
score (%)
Between group
difference (%)
P-value
qSOFA 22.5 2.0 20.5 <0.01
SIRS 4.3 1.2 3.1 0.010
qPELOD-2 36.4 2.6 33.8 <0.01
qSOFA-lactate 17.5 4.5 13.0 0.009
qSOFA < 2 (between group difference 20.5%, p < 0.01).
Sensitivity, specificity, negative predictive value and positive
predictive value of a positive qSOFA score for PICU transfer
and/or mortality were respectively 50.0, 93.3, 98.0, and 22.5%.
The positive qSOFA score AUROC for PICU transfer and/or
death was 0.72 (95% CI, 0.57–0.86) and 0.53 (95% CI, 0.46–0.59)
for prolonged hospital length of stay (Table 1).
The prognostic accuracy of the individual qSOFA
components, systolic blood pressure, level of consciousness
and respiratory rate, for PICU transfer and/or death were:
AUROC 0.56 (0.39–0.74), 0.74 (0.58–0.90), and 0.54 (0.43–
0.66), respectively. The prognostic accuracy of these individual
qSOFA components for prolonged hospital length of stay were:
AUROC 0.52 (0.44–0.60), 0.54 (0.47–0.61), and 0.50 (0.44–0.55),
respectively (Table 2).
Performance qSOFA Score Compared to
SIRS and qPELOD-2
The AUROC of a positive qSOFA score for predicting PICU
transfer and/or mortality tends to be higher than SIRS (AUROC,
0.64 [0.53–0.74], p = 0.23) and was significantly higher than
qPELOD-2 (AUROC, 0.60 [0.45–0.76], p= 0.03) (Figure 2). The
AUROC of a positive qSOFA score for predicting prolonged
hospital length of stay (0.53 [0.46–0.59]) was not comparable
to SIRS (AUROC, 0.49 [0.44–0.54], p = 0.82) and qPELOD-2
(AUROC, 0.51 [0.45–0.57], p = 0.25) (Table 1). The prognostic
accuracy of each individual SIRS component is presented in
Table 2.
Performance qSOFA-Lactate
Addition of venous lactate as an extra component to the qSOFA
score resulted in an AUROC of 0.67 (95% CI, 0.50–0.84) for
predicting PICU transfer/death and 0.56 (95% CI, 0.46–0.67)
for prolonged hospital length of stay (Figure 2). qSOFA-lactate
AUROC was significantly lower than qSOFA AUROC for PICU
transfer and/or mortality (p < 0.01) (Table 1).
DISCUSSION
This single-center retrospective study of 864 ED visits and
subsequent admissions for suspected bacterial infection, shows
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TABLE 2 | Prognostic accuracy of the individual components of qSOFA for PICU
transfer and/or mortality and prolonged hospital length of stay.
Primary outcome:
PICU transfer and/or
mortality
Secondary outcome:
Prolonged hospital
LOS (≥7 days)
Area under the curve
(95% CI)
Area under the curve
(95% CI)
qSOFA Systolic blood
pressure positivea
0.56 (0.39–0.74) 0.52 (0.44–0.60)
qSOFA Level of
consciousness positiveb
0.74 (0.58–0.90) 0.54 (0.47–0.61)
qSOFA/SIRS Respiratory
rate positivec
0.54 (0.43–0.66) 0.50 (0.44–0.55)
SIRS Temperature positived 0.58 (0.45–0.70) 0.47 (0.42–0.51)
SIRS Leukocyte count
positivee
0.49 (0.37–0.62) 0.54 (0.48–0.59)
SIRS Heart rate positivef 0.64 (0.51–0.76) 0.48 (0.43–0.53)
aData on qSOFA variable systolic blood pressure was available for 269/864 visits: 10/269
were systolic blood pressure positive [2/10 PICU transfer and/or mortality, 4/8 prolonged
hospital length of stay (2 unknown)], 259/269 were systolic blood pressure negative
[11/259 PICU transfer and/or mortality, 63/230 prolonged hospital length of stay (29
unknown)].
bData on qSOFA variable level of consciousness was available for 426/864 visits: 47/426
were level of consciousness positive [8/47 PICU transfer and/or mortality, 15/38 prolonged
hospital length of stay (9 unknown)], 379/426 were level of consciousness negative [6/379
PICU transfer and/or mortality, 77/355 prolonged hospital length of stay (24 unknown)].
cData on qSOFA and SIRS variable respiratory rate was available for 676/864
visits: 522/676 were respiratory rate positive [18/522 PICU transfer/mortality, 104/487
prolonged hospital length of stay (35 unknown)], 154/676 were respiratory rate negative
[3/154 PICU transfer and/or mortality, 31/140 prolonged hospital length of stay (14
unknown)].
dData on SIRS variable temperature was available for 855/864 visits: 302/855 were
temperature positive [11/302 PICU transfer and/or mortality, 53/282 prolonged hospital
length of stay (20 unknown)], 553/855 were temperature negative [11/553 PICU transfer
and/or mortality, 124/517 prolonged hospital length of stay (36 unknown)].
eData on SIRS variable leukocyte count was available for 663/864 visits: 341/633
were leukocyte count positive [11/341 PICU transfer and/or mortality, 78/310 prolonged
hospital length of stay (31 unknown)], 322/633 were leukocyte count negative [11/322
PICU transfer and/or mortality, 61/303 prolonged hospital length of stay (19 unknown)].
fData on SIRS variable heart rate was available for 783/864 visits: 222/783 were heart rate
positive [12/222 PICU transfer and/or mortality, 38/108 prolonged hospital length of stay
(14 unknown)], 561/783 were heart rate negative [10/561 PICU transfer and/or mortality,
116/520 prolonged hospital length of stay (41 unknown)].
that qSOFA is a moderate predictor of PICU transfer and/or
mortality in children. A previous study on qSOFA performance
in the pediatric ICU showed comparable moderate prognostic
accuracy of qSOFA for mortality (13). The discriminatory
capacity of qSOFA for prolonged hospital length of stay was poor.
This is not surprising since the qSOFA score was not validated for
hospital length of stay.
Although not significantly, the prognostic accuracy of qSOFA
for PICU transfer and/or mortality tends to be higher than
commonly used SIRS criteria. Our relatively small sample size
and small number of adverse events probably have hindered
this analysis. Therefore, larger studies in the near future
should compare qSOFA with other scores. qPELOD-2 has been
suggested as a reasonable alternative for qSOFA, since PELOD-
2 was found to discriminate decently for mortality in a PICU
population of children with suspected infection (17). However,
FIGURE 2 | Comparison of area under the receiver operating characteristics
curves for qSOFA, SIRS, qPELOD-2, and qSOFA-L scores to discriminate
primary outcome (PICU transfer and/or mortality).
the prognostic accuracy for PICU transfer and/or mortality
was significantly higher for qSOFA than qPELOD-2 in our
cohort.
To further improve predictive accuracy, we explored whether
the addition of lactate would be beneficial. A recent study
in children reported a strong and independent association
between increased lactate levels and mortality risk in the
PICU (21). Furthermore, lactate has been shown to predict
pediatric sepsis severity and was suggested to have utility in
early risk stratification (19, 22, 23). In our study, inclusion
of lactate in the qSOFA score decreased discriminatory
capacity for PICU transfer and/or mortality. It has to be
taken into consideration that this analysis is largely limited
by the small numbers of obtained venous lactate levels.
Moreover, arterial and capillary lactate measurements were
unknown.
It could be debatable whether the included qSOFA variables
(blood pressure, respiratory rate, and altered mental state) are
sufficient in predicting outcome for children with infections.
When looking at the prognostic accuracy of the individual
qSOFA variables, systolic blood pressure and respiratory rate
were poor predictors for PICU transfer and/or death, while
level of consciousness showed to have moderate prognostic
accuracy, similar to the qSOFA score. Arterial hypotension
is known to be a very late sign of pediatric sepsis with
poor sensitivity (24, 25), suggesting that blood pressure is
not suitable in early detection of patients at risk for poor
outcome. Secondly, respiratory rate could be influenced by
many non-infectious factors, such as pain and inconvenience.
Thus, the blood pressure and respiratory rate variables
included in qSOFA may be aspecific for children and we
question whether these variables will result in an adequate
bedside prediction tool. Possibly, an algorithm applied to
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larger datasets of children with suspected infection could
identify other suitable variables, either individually (e.g.,
level of consciousness, lactate) or as an addition to the
qSOFA score. For example, heart rate has been suggested
to be superior to respiratory rate in predicting critical care
requirement (26). This trend was also seen in our cohort. Future
studies are therefore urgently needed to identify parameters
which could be useful in predicting adverse outcome in
the ED.
The results of our study need to be interpreted with caution
because this study is limited by the small sample size, high
percentage of missing (i.e., not obtained) data, and relatively
small number of adverse events. Future multicenter studies in
larger populations are needed to draw firmer conclusions. In
children with (suspected) bacterial infections presenting to the
ED, mortality ranges from 0 to 2.2% and PICU transfer from
5.7 to 42% (22, 27–29). In our cohort, mortality (0.7%) and
PICU transfer (2.1%) was lower. The reason for this is unclear;
possibly, our cohort from a non-academic (secondary care)
hospital involves children with relatively milder illness severity
as compared to academic hospitals. Another reason could be
that the threshold to admit patients and start antibiotics is
lower in this center compared to others. However, children
suspected for bacterial infections are managed according to
our national guidelines. Furthermore, a large proportion of
data was not obtained. Because our ED triage system does
not oblige assessment of systolic blood pressure and level
of consciousness, we hypothesize that these parameters have
not been obtained in children not appearing ill. Our cohort
also includes children with viral infections, resulting from
our definition of suspected bacterial infection as initiation of
antibiotic therapy within 24 h after ED entry without taking
microbiology results into account. Ideally, prognostic scores
should be evaluated in confirmed bacterial infections or in
all febrile children visiting the ED. Another limitation of
our study is that we were unable to adjust for comorbidities
in the AUROC analysis, due to unknown data on patient
history. Also, parameters (of score components) could have
been measured at different times for different patients and since
we monitored adverse outcomes during hospital stay, i.e., also
past 24 h, the qSOFA score may not accurately reflect illness
severity.
In conclusion, this is the first study to assess qSOFA
criteria in a pediatric ED population. Since we compared
qSOFA with other prognostic scores, our study contributes
to current attempts to translate sepsis-3 criteria to children.
qSOFA shows moderate prognostic accuracy for PICU transfer
and/or mortality. The prognostic accuracy of qSOFA tends
to be higher than SIRS and is significantly higher than
qPELOD-2. Prognostic accuracy of qSOFA did not improve
after inclusion of lactate. Prospective multicenter studies in
larger ED populations of febrile children should be performed
to further determine the utility of the qSOFA score in the
pediatric ED. Pediatric sepsis researchers should assure that
pediatric Sepsis-3 criteria are applicable to ED patients as
well.
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